Tower Research Capital (TRC)’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9K | Buy |
|
|||||
|
2025
Q1 | $8.33K | Sell |
|
|||||
|
2024
Q4 | $26.2K | Buy |
|
|||||
|
2024
Q3 | $29.3K | Sell |
|
|||||
|
2024
Q2 | $153K | Buy |
|
|||||
|
2024
Q1 | $1.01K | Sell |
|
|||||
|
2023
Q4 | $54.8K | Buy |
|
|||||
|
2023
Q3 | $20.6K | Sell |
|
|||||
|
2023
Q2 | $195K | Buy |
|
|||||
|
2023
Q1 | $36K | Sell |
|
|||||
|
2022
Q4 | $51K | Sell |
|
|||||
|
2022
Q3 | $130K | Sell |
|
|||||
|
2022
Q2 | $215K | Buy |
|
|||||
|
2022
Q1 | $24K | Sell |
|
|||||
|
2021
Q4 | $331K | Buy |
|
|||||
|
2021
Q3 | $175K | Sell |
|
|||||
|
2021
Q2 | $164K | Buy |
|
|||||
|
2021
Q1 | $63K | Buy |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $302K | Buy |
|
|||||
|
2020
Q2 | $24K | Buy |
|